首页> 外国专利> SUSTAINED RELEASE PELLET COMPOSITION FOR ORAL ADMINISTRATION OF TAMSULOSIN HYDROCHLORIDE, TAMUSULOSIN HYDROCHLORIDE PREPARATION FOR ORAL ADMINISTRATION AND METHOD FOR PRODUCING THE SAME

SUSTAINED RELEASE PELLET COMPOSITION FOR ORAL ADMINISTRATION OF TAMSULOSIN HYDROCHLORIDE, TAMUSULOSIN HYDROCHLORIDE PREPARATION FOR ORAL ADMINISTRATION AND METHOD FOR PRODUCING THE SAME

机译:缓释球蛋白氢氧根的缓释丸组合物,牛磺球蛋白氢氧根的口服给药的制备方法及其制备方法

摘要

PPROBLEM TO BE SOLVED: To obtain a sustained release pellet composition for oral administration of tamsulosin hydrochloride having a uniform elution rate, and to provide a method for producing the same. PSOLUTION: The sustained release pellet composition for oral administration of tamsulosin hydrochloride contains the followings (a), (b) and (c). (a) 300-1,000 pts. wt. core; (b) a primary release-adjusting layer containing 1 pt. wt. tamsulosin hydrochloride, 200-600 pts. wt. primary release-adjusting agent selected from the group consisting of a methacrylic acid-ethyl acrylate copolymer, an ethyl cellulose and a polyvinyl acetate and 0.5-3 pts. wt. releasing assistant of at least 1 kind selected from the group consisting of an alginic acid salt, microcrystalline cellulose and sodium salt of carboxymethylcellulose; and (c) a secondary release-adjusting layer containing 1-10 pts. wt. secondary release-adjusting agent selected from the group consisting of ethylcellulose, Eudragit L100 and Eudragit S100. PCOPYRIGHT: (C)2005,JPO&NCIPI
机译:解决的问题:获得具有均匀洗脱速率的用于口服坦索罗辛盐酸盐的缓释丸剂组合物,并提供其制备方法。

解决方案:口服坦索罗辛盐酸盐的缓释微丸组合物包含以下(a),(b)和(c)。 (a)300-1,000点重量核心; (b)包含1磅的主要释放调节层。重量盐酸坦索罗辛200-600分重量选自甲基丙烯酸-丙烯酸乙酯共聚物,乙基纤维素和聚乙酸乙烯酯的主要释放调节剂为0.5-3pts。重量选自海藻酸盐,微晶纤维素和羧甲基纤维素钠盐中的至少一种的释放助剂; (c)包含1-10点的第二释放调节层。重量次级释放调节剂选自乙基纤维素,Eudragit L100和Eudragit S100。

版权:(C)2005,JPO&NCIPI

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号